+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Adrenal Corticosteroid Inhibitors Market by Route Of Administration, Mechanism Of Action, Application, Distribution Channel, Molecule Type, End User - Global Forecast to 2030- Product Image
Adrenal Corticosteroid Inhibitors Market by Route Of Administration, Mechanism Of Action, Application, Distribution Channel, Molecule Type, End User - Global Forecast to 2030- Product Image
Sale

Adrenal Corticosteroid Inhibitors Market by Route Of Administration, Mechanism Of Action, Application, Distribution Channel, Molecule Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5313709
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The adrenal corticosteroid inhibitors market is rapidly evolving, characterized by increasing therapeutic complexity, stringent regulatory expectations, and intensifying competition. Senior executives seeking to navigate this specialized sector require actionable intelligence on shifting preferences, investment priorities, and operational risks impacting long-term opportunity.

Market Snapshot: Adrenal Corticosteroid Inhibitors Market

The Adrenal Corticosteroid Inhibitors Market grew from USD 2.80 billion in 2024 to USD 3.17 billion in 2025. It is expected to continue growing at a CAGR of 12.85%, reaching USD 5.79 billion by 2030. Market expansion reflects heightened prevalence of endocrine and inflammatory diseases and a pronounced shift toward precision medicine. Global trends, such as streamlined regulatory pathways and advances in drug delivery, now influence competitive positioning in key therapeutic areas. This momentum, combined with geographic diversification and shifting tariff structures, is reshaping investment strategies and vendor partnerships across the sector.

Scope & Segmentation

This report delivers a detailed segmentation analysis and sector view for leaders:

  • Route of Administration: Injectable (intramuscular, intravenous, subcutaneous); Oral (capsules, tablets); Topical (cream, gel, ointment)
  • Mechanism of Action: Nonselective inhibitors; Selective 11β-HSD1 inhibitors
  • Application Areas: Addison's disease, asthma, Cushing’s syndrome, psoriasis, rheumatoid arthritis
  • Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy
  • Molecule Types: Semi-synthetic (modified natural, natural derivative); Synthetic (derivatives, full synthesis)
  • End Users: Clinics, home care, hospitals
  • Regional Coverage: Americas (including United States, Canada, Brazil), Europe, Middle East & Africa (notably Western Europe, Gulf states), Asia-Pacific (with strong growth in China, India, Japan, and emerging South-East Asia)
  • Technological Innovations: Novel drug delivery platforms, digital health integration for trial management, adaptive manufacturing strategies

Key Takeaways

  • Breakthroughs in molecular design and greater focus on precision therapies are setting a new standard for safety and patient outcomes in metabolic and inflammatory indications.
  • Supply chain resilience is now a core differentiator, with many industry players pursuing dual-sourcing and onshoring initiatives to reduce risk and adapt to regulatory shifts.
  • Strategic partnerships between pharmaceutical firms and research centers are accelerating the translation of preclinical discovery into clinical candidates, expanding access to specialized inhibitors.
  • Segmented delivery—ranging from injectables for hospital use to oral and topical preparations for chronic or localized management—enables alignment with sharply defined patient needs and reimbursement dynamics.
  • Competitive dynamics are intensifying as established producers expand portfolios through acquisitions while smaller biotechs leverage specialized expertise in enzyme selectivity and real-time patient data to disrupt the status quo.
  • Structural changes in reimbursement and launch strategies are occurring, especially in regions with stringent pricing controls or expanding healthcare access initiatives.

Tariff Impact on the Adrenal Corticosteroid Inhibitors Market

The 2025 introduction of United States tariffs on corticosteroid APIs from key European and Asian suppliers created new cost and logistics pressures for manufacturers. These measures have prompted pharmaceutical producers to diversify suppliers, adjust inventory controls, and consider alternative regions for sourcing. Finished product manufacturers also report longer lead times and higher freight costs, which is driving a systemic review of procurement agreements and a focus on mitigating future geopolitical risk in supply chain management.

Methodology & Data Sources

The insights in this report are built on a hybrid methodology, combining structured interviews with senior leadership, clinicians, and regulatory experts, alongside analysis of peer-reviewed literature, clinical trial data, and market filings. Both quantitative triangulation and qualitative scenario modeling support each conclusion, with all data validated through interdisciplinary reviews for accuracy and relevance.

Why This Report Matters

  • Enables senior decision-makers to align R&D and investment strategy with the most promising therapeutic and regional opportunities.
  • Equips leadership with actionable recommendations to mitigate operational risk arising from tariff changes, supply chain disruptions, and evolving reimbursement standards.
  • Delivers competitive intelligence highlighting partner dynamics, innovation hotspots, and nuanced differentiation by technology, geography, and clinical application.

Conclusion

This research provides senior executives with a strategic roadmap for capitalizing on innovation and minimizing disruption in the adrenal corticosteroid inhibitors market. Clear segmentation, targeted insights, and a rigorous methodology support precision decision-making in a fast-changing sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Adrenal Corticosteroid Inhibitors Market, by Route Of Administration
8.1. Introduction
8.2. Injectable
8.2.1. Intramuscular
8.2.2. Intravenous
8.2.3. Subcutaneous
8.3. Oral
8.3.1. Capsules
8.3.2. Tablets
8.4. Topical
8.4.1. Cream
8.4.2. Gel
8.4.3. Ointment
9. Adrenal Corticosteroid Inhibitors Market, by Mechanism Of Action
9.1. Introduction
9.2. Non Selective Inhibitors
9.3. Selective 11ß-Hsd1 Inhibitors
10. Adrenal Corticosteroid Inhibitors Market, by Application
10.1. Introduction
10.2. Addison's Disease
10.3. Asthma
10.4. Cushing's Syndrome
10.5. Psoriasis
10.6. Rheumatoid Arthritis
11. Adrenal Corticosteroid Inhibitors Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Adrenal Corticosteroid Inhibitors Market, by Molecule Type
12.1. Introduction
12.2. Semi Synthetic
12.2.1. Modified Natural
12.2.2. Natural Derivative
12.3. Synthetic
12.3.1. Derivatives
12.3.2. Full Synthesis
13. Adrenal Corticosteroid Inhibitors Market, by End User
13.1. Introduction
13.2. Clinic
13.3. Home Care
13.4. Hospital
14. Americas Adrenal Corticosteroid Inhibitors Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Adrenal Corticosteroid Inhibitors Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Adrenal Corticosteroid Inhibitors Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Teva Pharmaceutical Industries Ltd.
17.3.2. Viatris Inc.
17.3.3. Sandoz International GmbH
17.3.4. Perrigo Company plc
17.3.5. Recordati S.p.A.
17.3.6. Strongbridge Biopharma plc
17.3.7. Novartis AG
17.3.8. Corcept Therapeutics Incorporated
17.3.9. Bristol-Myers Squibb Company
17.3.10. HRA Pharma SAS
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ADRENAL CORTICOSTEROID INHIBITORS MARKET MULTI-CURRENCY
FIGURE 2. ADRENAL CORTICOSTEROID INHIBITORS MARKET MULTI-LANGUAGE
FIGURE 3. ADRENAL CORTICOSTEROID INHIBITORS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ADRENAL CORTICOSTEROID INHIBITORS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. ADRENAL CORTICOSTEROID INHIBITORS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ADRENAL CORTICOSTEROID INHIBITORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY OINTMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY NON SELECTIVE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SELECTIVE 11?-HSD1 INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ADDISON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY CUSHING'S SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MODIFIED NATURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY NATURAL DERIVATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY FULL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 71. CANADA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. CANADA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 73. CANADA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 74. CANADA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 75. CANADA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 76. CANADA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. CANADA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. CANADA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 79. CANADA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 80. CANADA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 81. CANADA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. MEXICO ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. MEXICO ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 84. MEXICO ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 85. MEXICO ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 86. MEXICO ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 87. MEXICO ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. MEXICO ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. MEXICO ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 90. MEXICO ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 91. MEXICO ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 92. MEXICO ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. GERMANY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. GERMANY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 140. GERMANY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 141. GERMANY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 142. GERMANY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 143. GERMANY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. GERMANY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. GERMANY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 146. GERMANY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 147. GERMANY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 148. GERMANY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. FRANCE ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 150. FRANCE ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 151. FRANCE ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 152. FRANCE ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 153. FRANCE ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 154. FRANCE ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. FRANCE ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. FRANCE ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 157. FRANCE ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 158. FRANCE ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 159. FRANCE ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. ITALY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 172. ITALY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 173. ITALY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 174. ITALY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 175. ITALY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 176. ITALY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. ITALY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. ITALY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 179. ITALY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 180. ITALY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 181. ITALY ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. SPAIN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 183. SPAIN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 184. SPAIN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 185. SPAIN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 186. SPAIN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 187. SPAIN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. SPAIN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. SPAIN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 190. SPAIN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 191. SPAIN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 192. SPAIN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. DENMARK ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 227. DENMARK ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 228. DENMARK ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 229. DENMARK ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 230. DENMARK ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 231. DENMARK ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. DENMARK ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. DENMARK ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 234. DENMARK ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 235. DENMARK ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 236. DENMARK ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. QATAR ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 249. QATAR ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 250. QATAR ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 251. QATAR ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 252. QATAR ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 253. QATAR ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. QATAR ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 255. QATAR ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 256. QATAR ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 257. QATAR ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 258. QATAR ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. FINLAND ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 260. FINLAND ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 261. FINLAND ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 262. FINLAND ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 263. FINLAND ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 264. FINLAND ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. FINLAND ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. FINLAND ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 267. FINLAND ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 268. FINLAND ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 269. FINLAND ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. SWEDEN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 271. SWEDEN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 272. SWEDEN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 273. SWEDEN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. NIGERIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 282. NIGERIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 283. NIGERIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SEMI SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY SYNTHETIC, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. EGYPT ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 293. EGYPT ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 294. EGYPT ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 295. EGYPT ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 296. EGYPT ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 297. EGYPT ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. EGYPT ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. EGYPT ADRENAL CORTICOSTEROID INHIBITORS MARKET SIZE, BY MOLECULE TYPE, 2018-203

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Adrenal Corticosteroid Inhibitors market report include:
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sandoz International GmbH
  • Perrigo Company plc
  • Recordati S.p.A.
  • Strongbridge Biopharma plc
  • Novartis AG
  • Corcept Therapeutics Incorporated
  • Bristol-Myers Squibb Company
  • HRA Pharma SAS

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.17 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.79 Billion
Compound Annual Growth Rate12.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Corticosteroids Therapy - Global Strategic Business Report - Product Image

Corticosteroids Therapy - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Corticosteroids Therapy Market by Route Of Administration, Indication, Drug Type, Dosage Form, Patient Age Group - Global Forecast to 2030 - Product Image

Corticosteroids Therapy Market by Route Of Administration, Indication, Drug Type, Dosage Form, Patient Age Group - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Non-Corticosteroid Immunomodulator Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Non-Corticosteroid Immunomodulator Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Corticosteroids Inhalation Formulation Market by End User, Indication, Distribution Channel, Dosage Form, Molecule - Global Forecast to 2030 - Product Image

Corticosteroids Inhalation Formulation Market by End User, Indication, Distribution Channel, Dosage Form, Molecule - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Corticosteroids Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Corticosteroids Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From

About the Adrenal Corticosteroid Inhibitors Market

Adrenal Corticosteroid Inhibitors (ACIs) are a type of immunosuppressive drug used to treat autoimmune diseases, such as rheumatoid arthritis, lupus, and psoriasis. ACIs work by blocking the production of cortisol, a hormone produced by the adrenal glands that can cause inflammation. This reduces the inflammation associated with autoimmune diseases, allowing the body to heal. ACIs are often used in combination with other immunosuppressive drugs, such as calcineurin inhibitors, to provide a more comprehensive treatment. ACIs are available in both oral and injectable forms, and can be used in both short-term and long-term treatments. Common side effects of ACIs include nausea, vomiting, and headaches. Some companies in the ACI market include AbbVie, Amgen, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.